- Home
- JOB vs LPCN Comparison
JOB vs LPCN Comparison
Compare JOB & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOB
- LPCN
- Stock Information
- Founded
- JOB 1893
- LPCN 1997
- Country
- JOB United States
- LPCN United States
- Employees
- JOB N/A
- LPCN N/A
- Industry
- JOB Diversified Commercial Services
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- JOB Consumer Discretionary
- LPCN Health Care
- Exchange
- JOB Nasdaq
- LPCN Nasdaq
- Market Cap
- JOB 24.7M
- LPCN 27.1M
- IPO Year
- JOB N/A
- LPCN N/A
- Fundamental
- Price
- JOB $0.26
- LPCN $4.37
- Analyst Decision
- JOB
- LPCN Strong Buy
- Analyst Count
- JOB 0
- LPCN 1
- Target Price
- JOB N/A
- LPCN $10.00
- AVG Volume (30 Days)
- JOB 11.0M
- LPCN 34.0K
- Earning Date
- JOB 02-11-2025
- LPCN 03-06-2025
- Dividend Yield
- JOB N/A
- LPCN N/A
- EPS Growth
- JOB N/A
- LPCN N/A
- EPS
- JOB N/A
- LPCN N/A
- Revenue
- JOB $116,483,000.00
- LPCN $7,922,926.00
- Revenue This Year
- JOB $43.94
- LPCN N/A
- Revenue Next Year
- JOB N/A
- LPCN N/A
- P/E Ratio
- JOB N/A
- LPCN N/A
- Revenue Growth
- JOB N/A
- LPCN N/A
- 52 Week Low
- JOB $0.20
- LPCN $3.20
- 52 Week High
- JOB $0.51
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- JOB 56.76
- LPCN 38.51
- Support Level
- JOB $0.22
- LPCN $4.48
- Resistance Level
- JOB $0.30
- LPCN $4.89
- Average True Range (ATR)
- JOB 0.04
- LPCN 0.35
- MACD
- JOB 0.01
- LPCN -0.06
- Stochastic Oscillator
- JOB 20.65
- LPCN 9.60
About JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.